American Scientific Resources Announces Launch of Heart Smart System(TM) Product Line

Company Forms Exclusive Partnership with Tishcon Corp. for Production of 100%

Soluble CoQ10 Supplement

May 04, 2005, 01:00 ET from American Scientific Resources

    NEW PALTZ, N.Y., May 4 /PRNewswire-FirstCall/ -- American Scientific
 Resources (PNK: ASFX) today announced the launch of its flagship Heart Smart
 System(TM), a unique line of nutraceutical products that assist in the
 successful prevention of cardiovascular disease.
     Heart Smart System(TM) is a nutritional line of supplements which support
 and maintain a healthy heart. American Scientific has formed an exclusive
 partnership with Tishcon Corp., a privately held contract manufacturer of
 nutritional supplements based in Westbury, NY, to produce the patented Heart
 Smart brand. Tishcon is licensed by the Food and Drug Administration (FDA).
     Heart Smart contains a proprietary blend that includes a 100% soluble
 supplement for Coenzyme Q10 (CoQ10), which is found in every cell of the body
 and is critical in the production of energy, and maintenance of healthy heart
 function. Through Heart Smart, the supply of CoQ10 is rejuvenated and yields
 numerous beneficial effects, including an overall healthier immune system.
 The goal is to help combat cardiovascular disease, which is attributed to
 approximately 1 million deaths or injuries per year in the U.S. and implicated
 in an additional 9 million deaths per year nationwide.
     Walter Lambert, Chairman and Chief Executive Officer of American
 Scientific stated, "The launch of our revolutionary flagship product
 represents a major milestone for our company. We are excited to partner with
 Tishcon to create our patented, clinically proven nutritional supplement that
 provides a safe and effective alternative for promoting heart health.  By
 focusing on the prevention of cardiovascular disease, we believe our Heart
 Smart System(TM) can relieve one of the leading causes of premature and
 avoidable deaths among adult Americans without incurring dramatic changes to a
 person's lifestyle."
     Mr. Lambert added, "Heart Smart is paramount in the execution of our
 growth strategy.  We are excited by Heart Smart's vast potential in the
 multi-billion dollar nutritional supplement market and look forward to
 educating consumers and building brand awareness as we roll out our products.
 We expect to expand the distribution of our Heart Smart System(TM) through a
 comprehensive direct marketing campaign as well as mass market retailers such
 as drug stores, grocery stores, mass merchandisers, and more."
     George McShane, Director of Sales and Marketing at Tishcon, said, "We are
 pleased to team with American Scientific. Our 30-year history in production of
 technologically advanced nutritional supplements combined with American
 Scientific's strong distribution platform provides a significant growth
 opportunity. We believe our patented nanotechnology, Biosolve(TM), for the
 100% dissolution of CoQ10 throughout the body presents a distinct advantage
 over other products in the market. Our initial plan is to offer Heart Smart
 via capsule tablet or chewable form and strengthen the human cardiovascular
 system for people throughout the U.S."
     About American Scientific Resources
     American Scientific Resources, Inc. is an emerging holding company based
 in upstate New York that provides a broad range of healthcare and medical
 products distributed primarily by surgical supply dealers and retail drug
 chains. The company is comprised of three core operating subsidiaries: 1)
 Heart Smart System, Inc., the company's flagship product offering focused on
 the successful prevention of cardiovascular disease using its patented CoQ10
 supplement 2) Kidz-Med, Inc., a leading brand of safe and innovative pediatric
 products, and 3) Ulster Scientific, Inc., a manufacturer and distributor of
 unique medical products and laboratory diagnostic equipment founded in 1974.
 American Scientific Resources' growing, national customer base includes
 Walgreens, CVS, Cardinal Health and Fisher Scientific.
     SAFE HARBOR STATEMENT: This news release contains "forward-looking
 statements" that are made pursuant to the safe harbor provisions of the
 Private Securities Litigation Reform Act of 1995. "Forward- looking
 statements" describe future expectations, plans, results, or strategies and
 are generally preceded by words such as "future," "plan" or "planned," "will"
 or "should," "expected," "anticipates," "draft," "eventually" or "projected".
 You are cautioned that such statements are subject to a multitude of risks and
 uncertainties that could cause future circumstances, events or results to
 differ materially from those projected in the forward-looking statements,
 including the risks that our products may not achieve customer acceptance or
 that they will not perform as expected, that customer trials will not lead to
 future sales, and other risks identified in our annual report on Form 10-K and
 other filings with the SEC. You should consider these factors in evaluating
 the forward-looking statements included herein, and not place undue reliance
 on such statements. The forward-looking statements are made as of the date
 hereof and DVS undertakes no obligation to update such statements.

SOURCE American Scientific Resources